KOSDAQ · Healthcare · ₩222B
₩15,900+6.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.6% · as of 26.09.11
Among 15 신약 개발 peers
“치료제 개발이 진전되며 다음 성장의 문을 열고 있어요.”
In the company's words · 2026 2분기 filing